已收盘 02-06 16:00:00 美东时间
+0.840
+4.01%
今日重点评级关注:巴克莱:维持Iovance Biotherapeutics"超配"评级,目标价从9美元升至10美元;摩根大通:上调Recursion Pharmaceuticals评级至"超配",目标价从10美元升至11美元
2025-12-18 10:54
今日重点评级关注:HC Wainwright & Co.:维持BioCryst Pharma"买入"评级,目标价从30美元升至32美元;TD Cowen:上调Milestone Pharmaceuticals评级至"买入",目标价8美元
2025-12-16 09:36
Ingram Micro Holding shares are trading higher after the company reported bette...
2025-11-01 03:12
Raymond James analyst Adam Tindle maintains Ingram Micro Holding (NYSE:INGM) with a Outperform and lowers the price target from $26 to $24.
2025-08-07 21:02
今日重点评级关注:花旗:维持百度"买入"评级,目标价从138美元升至140美元;Maxim Group:维持Caledonia Mining"买入"评级,目标价从21美元升至28美元
2025-07-18 09:25
JP Morgan analyst Samik Chatterjee maintains Ingram Micro Holding (NYSE:INGM) with a Neutral and raises the price target from $21 to $24.
2025-07-18 02:13
An announcement from Ingram Micro Holding Corporation ( ($INGM) ) is now availa...
2025-07-07 20:14
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1139839943846023169.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Loop Capital:维持Dave & Buster's Enter(PLAY)"买入"评级,目标价从35美元升至46美元</p> <p>• Stifel:维持嘉年华(CCL)"买入"评级,目标价从31美元升至
2025-06-12 09:46
Latest 13F filings reveal that the first quarter of 2025 saw institutional investors significantly retreating from the technology sector.
2025-06-12 00:01